CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Silence Therapeutics Plc Company Snapshot
Silence Therapeutics Plc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Silence Therapeutics Plc with three other companies in this sector in the United Kingdom: Tissue Regenix Group PLC (2016 sales of £816,000.00 [US$1.06 million] of which 108% was Wound Care), Realm Therapeutics PLC (£644,819.07 [US$839,606.02 ] of which 100% was Health Sciences), and Oxford Pharmascience Group PLC (£796,000.00 [US$1.04 million] of which 100% was Delivery systems).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Silence Therapeutics Plc
  Stock Performance Chart for Silence Therapeutics Plc
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 96.25p
(Figures in Pounds Sterling)
1 Week 13.2%   13 Weeks 11.6%  
4 Weeks -4.7%   52 Weeks -17.2%  
 
Silence Therapeutics Plc Key Data:
  Ticker: SLN Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 770,000
(Year Ending Jan 2017).
Employees: 59
  Currency: Pounds Sterling Market Cap: 67,366,938
  Fiscal Yr Ends: December Shares Outstanding: 69,991,624
  Share Type: Ordinary Closely Held Shares: 35,621,684
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.